Stock DNA
Pharmaceuticals & Biotechnology
CNY 6,247 Million (Mid Cap)
7.00
NA
9.38%
-1.10
29.85%
2.10
Revenue and Profits:
Net Sales:
412 Million
(Quarterly Results - Mar 2026)
Net Profit:
209 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.09%
0%
-9.09%
6 Months
-15.23%
0%
-15.23%
1 Year
-6.21%
0%
-6.21%
2 Years
-9.09%
0%
-9.09%
3 Years
-20.62%
0%
-20.62%
4 Years
-32.18%
0%
-32.18%
5 Years
7.91%
0%
7.91%
Shandong Wit Dyne Health Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.53%
EBIT Growth (5y)
7.21%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.78
Tax Ratio
14.60%
Dividend Payout Ratio
109.41%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
291.53%
ROE (avg)
33.88%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
2.10
EV to EBIT
3.05
EV to EBITDA
2.88
EV to Capital Employed
-10.26
EV to Sales
1.47
PEG Ratio
NA
Dividend Yield
9.38%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
29.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
412.30
625.80
-34.12%
Operating Profit (PBDIT) excl Other Income
233.70
298.10
-21.60%
Interest
0.00
0.00
Exceptional Items
3.60
-1.50
340.00%
Consolidate Net Profit
209.40
261.10
-19.80%
Operating Profit Margin (Excl OI)
566.90%
444.10%
12.28%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -34.12% vs 44.83% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -19.80% vs 103.67% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,197.60
2,098.10
4.74%
Operating Profit (PBDIT) excl Other Income
1,239.30
1,183.00
4.76%
Interest
0.30
0.50
-40.00%
Exceptional Items
-14.70
10.00
-247.00%
Consolidate Net Profit
1,028.50
1,006.00
2.24%
Operating Profit Margin (Excl OI)
529.80%
527.00%
0.28%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 4.74% vs -14.50% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 2.24% vs -10.74% in Dec 2024
About Shandong Wit Dyne Health Co., Ltd. 
Shandong Wit Dyne Health Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






